Immuno-oncology technology

查看最新文献

5314

CiteScore	SJR	SNIP	CiteScore排名
5.4	1.987	0.696	学科排名百分位大类：Medicine 小类：Oncology 152 / 404 62% 大类：Medicine 小类：Immunology and Allergy 116 / 233 50%

Immuno-oncology technology - 最新文献

Redirecting engineered immune cells using G protein-coupled receptors in cancer therapy

Pub Date : 2026-03-01 DOI: 10.1016/j.iotech.2026.101582 W. den Hartog , J. Harwood , S. Kobold

Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial)

Pub Date : 2026-03-01 DOI: 10.1016/j.iotech.2025.101077 N. Alshatti , F. Lemonnier , E. Bachy , J. Lopez , F. Llamas , D. Damotte , B. Burron , Y. Velut , C. Mauduit , M. de Charette , M. Roussel , X. Palard , A. Marabelle , R. Huot

Safety of intratumoral immunostimulatory LOAd703 gene therapy combined with chemotherapy in patients with advanced cancer

Pub Date : 2026-03-01 DOI: 10.1016/j.iotech.2026.101585 A. Hahn , S. Irenaeus , L.C. Sandin , J. Wenthe , E. Eriksson , J.L. Jarblad , A. Schiza , H. Dahlstrand , U. Olsson-Strömberg , J. Krause , A. Sundin , A. Loskog , G.J. Ullenhag

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。